Share Buyback
EKF Diagnostics Holdings plc has purchased 30,000 ordinary shares at a weighted average price of 23.4 pence per share, with these shares to be held in treasury. Following this buyback, the company's total issued share capital stands at 431,963,112 ordinary shares, with 995,000 held in treasury, resulting in 430,968,112 ordinary shares carrying voting rights.
Select text to share a quote on X · sign in to keep highlights & notes in your EKF notes
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that it has purchased a total of 30,000 of its ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at a weighted average price of 23.4 pence per share. The Ordinary Shares purchased will be held in treasury. Harwood Capital Management has not sold any ordinary shares to the Company as part of yesterday's purchases.
Aggregated information
| Date of purchase | 1 April 2026 | ||
|---|---|---|---|
| Number of Ordinary Shares purchased | 30,000 | ||
| Highest price paid per Ordinary Share | 23.4p | ||
| Lowest price paid per Ordinary Share | 23.4p | ||
| Volume weighted average price paid | 23.4p | ||
| Transaction details | |||
| Number of Ordinary Shares purchased | Transaction price (GBp) | Time of transaction | Trading venue |
| 30,000 | 23.4p | 16:26:30 | AIMX |
Total voting rights
Following the purchase, the Company's total issued share capital will consist of 431,963,112 Ordinary Shares, of which 995,000 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 430,968,112. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The person responsible for arranging the release of this Announcement
on behalf of the Company is Julian Baines, Executive Chair.
| EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
| Julian Baines, Executive Chair | via Walbrook PR |
| Gavin Jones, Chief Executive Officer | |
| Singer Capital Markets (Nominated Adviser & Broker) | Tel: +44 (0)20 7496 3000 |
| Phil Davies / Patrick Weaver | |
| Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0) 7407 804 654 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.